Vasopressors and Nutrition Therapy: Safe Dose for the Outset of Enteral Nutrition?

Background and Aims. Patients with hemodynamic instability need to receive intensive treatment as fluid replacement and vasoactive drugs. In the meantime, it is supposed to initiate nutritional therapy within 24 to 48 hours after admission to the intensive care unit (ICU), as an essential part of pa...

Full description

Bibliographic Details
Main Authors: Luís Henrique Simões Covello, Marcella Giovana Gava-Brandolis, Melina Gouveia Castro, Martins Fidelis Dos Santos Netos, William Manzanares, Diogo Oliveira Toledo
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:Critical Care Research and Practice
Online Access:http://dx.doi.org/10.1155/2020/1095693
id doaj-6a84d08dd34f4c798ef51831e99737c9
record_format Article
spelling doaj-6a84d08dd34f4c798ef51831e99737c92020-11-25T02:52:04ZengHindawi LimitedCritical Care Research and Practice2090-13052090-13132020-01-01202010.1155/2020/10956931095693Vasopressors and Nutrition Therapy: Safe Dose for the Outset of Enteral Nutrition?Luís Henrique Simões Covello0Marcella Giovana Gava-Brandolis1Melina Gouveia Castro2Martins Fidelis Dos Santos Netos3William Manzanares4Diogo Oliveira Toledo5Department of Critical Care of Barretos Cancer Hospital, Barretos, BrazilDepartment of Research of Hospital São Luis Itaim, São Paulo, BrazilDepartment of Education of Hospital Israelita Albert Einstein, São Paulo, BrazilDepartment of Science Information of Barretos Cancer Hospital, Barretos, BrazilDepartment of Critical Care, University Hospital of Universidad de la Republica (UDELAR), Montevideo, UruguayDepartment of Critical Care of Hospital Israelita Albert Einstein, São Paulo, BrazilBackground and Aims. Patients with hemodynamic instability need to receive intensive treatment as fluid replacement and vasoactive drugs. In the meantime, it is supposed to initiate nutritional therapy within 24 to 48 hours after admission to the intensive care unit (ICU), as an essential part of patient’s intensive care and better outcomes. However, there are many controversies tangential to the prescription of enteral nutrition (EN) concomitant to the use of vasopressor and its doses. In this way, the present study aimed to identify what the literature presents of evidence to guide the clinical practice concerning the safe dose of vasopressors for the initiation of nutritional therapy in critically ill patients. Methods. This review was carried out in PubMed, ProQuest, Web of Science, and Medline databases. The descriptors were used to perform the search strategy: Critical Care, Intensive Care Units, Vasoconstrictor Agents, and Enteral Nutrition. Inclusion criteria were patients of both genders, over 18 years of age, using vasoactive drugs, with the possibility of receiving EN therapy, and articles written in English, Portuguese, and Spanish. In addition, exclusion criteria were case reports, non-papers, and repeated papers. Results. 10 articles met our inclusion criteria. Conclusion. It was observed that there are many controversies about the supply of EN in critically ill patients using vasopressor, especially about the safe dose, and it was not possible to identify a cutoff value for the beginning therapy. Despite the drug doses, clinical signs are still the most important parameters in the evaluation of EN tolerance.http://dx.doi.org/10.1155/2020/1095693
collection DOAJ
language English
format Article
sources DOAJ
author Luís Henrique Simões Covello
Marcella Giovana Gava-Brandolis
Melina Gouveia Castro
Martins Fidelis Dos Santos Netos
William Manzanares
Diogo Oliveira Toledo
spellingShingle Luís Henrique Simões Covello
Marcella Giovana Gava-Brandolis
Melina Gouveia Castro
Martins Fidelis Dos Santos Netos
William Manzanares
Diogo Oliveira Toledo
Vasopressors and Nutrition Therapy: Safe Dose for the Outset of Enteral Nutrition?
Critical Care Research and Practice
author_facet Luís Henrique Simões Covello
Marcella Giovana Gava-Brandolis
Melina Gouveia Castro
Martins Fidelis Dos Santos Netos
William Manzanares
Diogo Oliveira Toledo
author_sort Luís Henrique Simões Covello
title Vasopressors and Nutrition Therapy: Safe Dose for the Outset of Enteral Nutrition?
title_short Vasopressors and Nutrition Therapy: Safe Dose for the Outset of Enteral Nutrition?
title_full Vasopressors and Nutrition Therapy: Safe Dose for the Outset of Enteral Nutrition?
title_fullStr Vasopressors and Nutrition Therapy: Safe Dose for the Outset of Enteral Nutrition?
title_full_unstemmed Vasopressors and Nutrition Therapy: Safe Dose for the Outset of Enteral Nutrition?
title_sort vasopressors and nutrition therapy: safe dose for the outset of enteral nutrition?
publisher Hindawi Limited
series Critical Care Research and Practice
issn 2090-1305
2090-1313
publishDate 2020-01-01
description Background and Aims. Patients with hemodynamic instability need to receive intensive treatment as fluid replacement and vasoactive drugs. In the meantime, it is supposed to initiate nutritional therapy within 24 to 48 hours after admission to the intensive care unit (ICU), as an essential part of patient’s intensive care and better outcomes. However, there are many controversies tangential to the prescription of enteral nutrition (EN) concomitant to the use of vasopressor and its doses. In this way, the present study aimed to identify what the literature presents of evidence to guide the clinical practice concerning the safe dose of vasopressors for the initiation of nutritional therapy in critically ill patients. Methods. This review was carried out in PubMed, ProQuest, Web of Science, and Medline databases. The descriptors were used to perform the search strategy: Critical Care, Intensive Care Units, Vasoconstrictor Agents, and Enteral Nutrition. Inclusion criteria were patients of both genders, over 18 years of age, using vasoactive drugs, with the possibility of receiving EN therapy, and articles written in English, Portuguese, and Spanish. In addition, exclusion criteria were case reports, non-papers, and repeated papers. Results. 10 articles met our inclusion criteria. Conclusion. It was observed that there are many controversies about the supply of EN in critically ill patients using vasopressor, especially about the safe dose, and it was not possible to identify a cutoff value for the beginning therapy. Despite the drug doses, clinical signs are still the most important parameters in the evaluation of EN tolerance.
url http://dx.doi.org/10.1155/2020/1095693
work_keys_str_mv AT luishenriquesimoescovello vasopressorsandnutritiontherapysafedosefortheoutsetofenteralnutrition
AT marcellagiovanagavabrandolis vasopressorsandnutritiontherapysafedosefortheoutsetofenteralnutrition
AT melinagouveiacastro vasopressorsandnutritiontherapysafedosefortheoutsetofenteralnutrition
AT martinsfidelisdossantosnetos vasopressorsandnutritiontherapysafedosefortheoutsetofenteralnutrition
AT williammanzanares vasopressorsandnutritiontherapysafedosefortheoutsetofenteralnutrition
AT diogooliveiratoledo vasopressorsandnutritiontherapysafedosefortheoutsetofenteralnutrition
_version_ 1715365529226575872